In particular, high L1CAM expression observed in the aggressive ARMS histological subtype, and its inverse correlation with survival, support further investigation of L1CAM targeted therapies for patients with dismal prognosis. The gene discussed is L1CAM; the disease is alveolar rhabdomyosarcoma.